Physician

Eduardo Dusty Luna, M.D.

According to 2025 Medicare claims, Eduardo Luna, M.D. (NPI: 1073959326) practices endocrinology in the McAllen-Edinburg-Mission, TX market, with the plurality of this provider's patient population coming from Hidalgo, TX. This provider's primary affiliated billing organization is VALLEY DIABETES & ENDOCRINOLOGY COMPREHENSIVE CENTER P.L.L.C. (NPI: 1376109637; TIN: 834284327) and primary practice location at 78504-3288.

Luna's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 228 traditional Medicare patients, billed 9,879 HCPCS/CPT codes, and received $166,744 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 4,828 prescription claims across 727 beneficiaries totaling $9,130,514 in drug costs, led by Korlym (Mifepristone). DME data shows 155 claims. Open Payments data shows 597 records totaling $2,767,741. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $15,947 to $166,744. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,036 to $9,130,514. For DME billing, reported payments moved sharply higher in recent years, from $11,134 to $64,216.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	101	368	$15,947
2019	283	1,667	$59,583
2020	195	818	$34,210
2021	166	645	$54,364
2022	188	909	$64,383
2023	206	1,574	$85,319
2024	228	9,879	$166,744

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	25	132	$2,036
2016	20	186	$9,087
2017	15	45	$18,138
2018	200	703	$269,303
2019	428	2,783	$1,372,165
2020	468	2,567	$1,371,396
2021	395	2,475	$2,047,178
2022	446	2,695	$2,460,750
2023	566	3,773	$5,260,835
2024	727	4,828	$9,130,514

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	29	95	$12,817
2020	53	159	$14,109
2021	18	92	$16,575
2022	44	209	$38,705
2023	53	288	$54,757
2024	50	155	$59,562

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	65	92	$119
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	202	484	$86
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	65	147	$24
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	141	236	$11
83036	Hemoglobin a1c level	27	30	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Korlym	Mifepristone	120	3,600	$4,706,052
Strensiq	Asfotase Alfa	23	644	$1,235,434
Mounjaro	Tirzepatide	797	30,022	$1,085,838
Ozempic	Semaglutide	230	10,368	$327,897
Synjardy Xr	Empagliflozin/Metformin Hcl	195	12,870	$230,808

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	38	132	$53,127
E0784	External ambulatory infusion pump, insulin	Y	N/R	11	$3,720
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	12	12	$2,714

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	544	$296,175	Corcept Therapeutics
Research Payments	Reported research-related payment or transfer-of-value amount.	53	$2,471,567	Eli Lilly and Company
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Eduardo Dusty Luna, M.D.?

Tedicare shows public-source Medicare data for Eduardo Dusty Luna, M.D. (NPI 1073959326), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eduardo Dusty Luna, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Eduardo Dusty Luna, M.D.?

Eduardo Dusty Luna, M.D. is linked to VALLEY DIABETES & ENDOCRINOLOGY COMPREHENSIVE CENTER P.L.L.C. (billing NPI 1376109637) in the available physician profile data.

Does Eduardo Dusty Luna, M.D. have Open Payments data?

Eduardo Dusty Luna, M.D. has 597 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.